Jennifer Matthews: It's time for Camille Engelbert's regular visit to the doctor. Six months ago, she became one of the millions of Americans on the blood thinner Warfarin. While the drug can prevent potentially fatal blood clots from forming, it's a complex medication.
Dr. Jonathan L. Halperin: Not only do a zillion factors affect it, but in fact, you have to control it within a very narrow range.
Jennifer Matthews: Not enough and clots can form. Too much can cause bleeding. This means monthly blood tests and a close watch on diet and other drugs.
Camille Engelbert: I don't take anything without checking with Dr. Halperin or the office.
Jennifer Matthews: Now Doctor Jonathan Halperin is studying a new drug called Ximelagatran that he hopes will do the job of Warfarin without all the worries.
Dr. Jonathan L. Halperin: It acts in a different place in the body's biochemistry of clotting to allow it to be used as a single dose for all people.
Jennifer Matthews: A study in more than 3,000 patients had encouraging results.
Dr. Jonathan L. Halperin: Ximelagatran was at least effective as adjusted dose Warfarin in preventing strokes and actually caused less bleeding than Warfarin without the need for blood test monitoring or dose adjustment.
Jennifer Matthews: Doctor Halperin hopes that means more patients will get the treatment the need and thousands of strokes can be prevented. This is Jennifer Matthews reporting.
Transcription by:
Scribe4you Transcription Services